First Light Asset Management’s Emergent Biosolutions EBS Stock Holding History

First Light Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,294	Closed	-$215K	–	81
2021 Q3	$215K	Hold	4,294	–	–	0.01%	83
2021 Q2	$270K	Hold	4,294	–	–	0.02%	78
2021 Q1	$399K	Buy	+4,294	New	+$440K	0.03%	71

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Light Asset Management's EBS Position: Q4 2021 in Review

First Light Asset Management sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 4,294 shares — an estimated $215K sold.

First Light Asset Management first reported a position in EBS in Q1 2021 and held it in 3 quarters. The position peaked at $399K in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

First Light Asset Management reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
First Light Asset Management sold 4,294 Emergent Biosolutions shares in Q4 2021, an estimated $215K.
First Light Asset Management first reported a position in Emergent Biosolutions in Q1 2021 and held it in 3 quarters.
First Light Asset Management's Emergent Biosolutions position peaked at $399K in Q1 2021.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on First Light Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.